Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Bayer acquires Fosrenol rights in Japan

Dec. 12, 2003

Roche claims novel alpha1A-adrenoceptor agonists for urinary incontinence and other uses

Dec. 3, 2003

Enrollment completed in phase IIa BPH study of BXL-628

Dec. 2, 2003

New tachykinin NK1 antagonists and their use claimed by Kyorin team

Dec. 1, 2003

Improved penile erection in rats treated with ABT-724

Dec. 1, 2003

European CPMP issues positive opinion for oxybutynin transdermal patch

Nov. 26, 2003

New muscarinic M3 antagonists and their use in urinary incontinence, COPD, IBS, etc.

Nov. 25, 2003

Lilly Icos receives FDA approval for Cialis

Nov. 25, 2003

GPI-1485 enters phase II trial for postprostatectomy erectile dysfunction

Nov. 20, 2003

HCT-1026 and ibuprofen reduce resiniferatoxin-induced bladder hyperactivity in rats

Nov. 19, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...